Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y neuroblastoma cells through estrogen receptors alpha and beta

GRASSI D; BELLINI MJ; ACAZ-FONSECA E; PANZICA GC

TORINO, ITALIA

Congreso; 7TH MEETING STEROIDS AND NERVOUS SYSTEM; 2013

The expression of arginine-vasopressin (AVP) is regulated by estradiol and testosterone in different neuronal populations by mechanisms that are not yet fully understood. Estrogen receptors (ERs) have been shown to participate in the regulation of AVP neurons by estradiol. In addition, there is evidence of the participation of ERβ in the regulation of AVP expression exerted by testosterone via its metabolite 5α-dihydrotestosterone (5α-DHT) and its further conversion in the androgen metabolite and ERβ ligand 3β-diol. In this study we have explored the role of ERs in the regulation exerted by estradiol and testosterone on AVP expression, using the human neuroblastoma cell line SH-SY5Y. Estradiol treatment increased AVP mRNA levels in SH-SY5Y cells in comparison to cells treated with vehicle. The stimulatory effect of estradiol on AVP expression was imitated by the ERα agonist PPT and blocked by the ER antagonist, ICI 182,780 and the ERα antagonist MPP. In contrast, the ERβ agonist DPN reduced AVP expression, while the ERβ antagonist PHTPP enhanced the action of estradiol on AVP expression. Testosterone increased AVP expression in SH-SY5Y cells by a mechanism that was dependent on aromatase, but not on 5α-reducatse activity. Testosterone effect was not affected by blocking androgen receptor, was not imitated by the testosterone metabolite 5α-DHT, and was blocked by the ERα antagonist MPP. In contrast, 5α-DHT had a similar effect than the ERβ agonists DPN and 3β-diol, reducing AVP expression. These findings suggest that estradiol and testosterone regulate AVP expression in SH-SY5Y cells through ERs, exerting a stimulatory action via ERα and an inhibitory action via ERβ.